# ARCH CAPITAL GROUP LTD. (ACGLN) — Financial Analysis

**Exchange:** Nasdaq  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-06-12  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/ACGLN/thesis · /stocks/ACGLN/memo

## Financial Snapshot

---
ticker: ACGLN
company: Arch Capital Group Ltd.
step: "04"
title: Financial Statement Quality & Snapshot
source: coverage-next-full
date: 2026-06-10
---

### Step 04 — Financial Statement Quality & Snapshot
#### Arch Capital Group Ltd. (ACGL / ACGLN)

> **Research path note:** Transcript analysis not performed (coverage-next-full path). All data sourced from SEC EDGAR XBRL [S1], StockAnalysis.com [S2], DEF 14A proxy [S3], and insider/preferred filings [S4].

---

#### Source Index

| ID | Source |
|----|--------|
| S1 | SEC EDGAR XBRL Company Facts, CIK 0000947484 (fetched 2026-06-10) |
| S2 | StockAnalysis.com — ACGL financial summary (June 2026) |
| S3 | DEF 14A proxy filing, March 24, 2026 |
| S4 | SEC EDGAR Form 4 filings; insider_transactions.md (June 2026) |

> **Data reconciliation note:** StockAnalysis.com reports FY2025 net income of $4,219M [S2]; the XBRL filing reports $4,400M [S1]. The XBRL figure reconciles exactly to both (a) EPS: $11.60 diluted × 375.9M diluted shares + ~$40M preferred dividends = ~$4,400M attributable to ACGL, and (b) pre-tax/tax: $5,160M pretax − $760M tax = $4,400M at an effective 14.7% rate (consistent with the ~15% Bermuda Pillar Two rate effective January 2025). All GAAP net income figures in this analysis use the XBRL-sourced $4.40B.

---

#### 1. Statement Quality Assessment

##### 1a. Insurance GAAP Revenue Recognition

Arch Capital earns revenue primarily through net premiums earned (NPE), which totaled $17.07B in FY2025 [S1]. Insurance GAAP requires premiums to be recognized ratably over the policy period (the "earning" of unearned premiums). This is a straightforward, highly mechanical process — **revenue manipulation through accelerated premium recognition is structurally very difficult** in P&C/reinsurance accounting. Unearned premium reserves on the balance sheet act as a direct offset: if premiums are written but not yet earned, they sit in unearned premiums ($10.10B at YE2025 [S1]), providing external validation.

The gap between net premiums written (NPW $16.48B) and NPE ($17.07B) in FY2025 indicates that more premium was earned than written in the year — meaning the earned revenue outpaced new writings due to burn-down of the prior-year unearned premium reserve. This is a normal year-end dynamic reflecting strong prior growth and does not raise a quality concern.

##### 1b. Loss Reserve Adequacy and Prior-Period Development

Loss reserves (liability for claims and LAE) grew from $22.75B (2023) to $29.37B (2024) to $33.55B (2025) [S1]. The 2024 surge of $6.6B (+29% YoY) is notably large relative to premium growth of 17%, consistent with Arch writing significantly more long-tail liability and casualty business in its Insurance segment. Reserve adequacy is the **primary earnings quality risk** for P&C insurers.

**Historical development pattern:** ACGL has a track record of favorable prior-period development (PPD) — meaning actual claims have historically come in below initial reserve estimates. This is consistent with a conservative reserving culture under long-tenured management. However:
- Long-tail casualty lines (general liability, professional liability, umbrella) carry significant uncertainty that may not surface for 3–7+ years
- Social inflation, nuclear verdicts, and third-party litigation funding have systematically caused reserve deficiencies industry-wide in the 2019–2024 accident years
- The Insurance segment's FY2025 combined ratio of ~91% (vs. Reinsurance ~85% and Mortgage 13–35%) [S2] reflects higher loss ratios in the Insurance book

> **Key risk:** Whether loss reserves for 2022–2025 accident years in long-tail casualty are adequate given the ongoing social inflation environment. This cannot be assessed without actuarial disclosure, but Arch's reserve growth ($11B over two years) signals management is actively strengthening — a positive indicator for conservatism.

##### 1c. GAAP vs. Operating Income Divergence

The primary reconciling item between GAAP net income and after-tax operating income is **realized and unrealized investment gains/losses**:

| Metric | FY2025 | FY2024 | FY2023 |
|--------|--------|--------|--------|
| GAAP Net Income (XBRL) [S1] | $4.40B | $4.31B | $4.44B |
| After-Tax Operating NI [S2] | $3.70B | ~$3.30B est. | ~$2.8B est. |
| GAAP vs. Operating Difference | ~$0.70B | ~$1.0B | ~$1.6B |
| Diluted EPS (GAAP) [S1] | $11.60 | $11.19 | $11.62 |
| Operating EPS [S2] | $9.84 | ~$9.0E | ~$7.5E |

The FY2023 GAAP net income spike to $4.44B is partly explained by a $873M income tax **benefit** (vs. expenses in other years) [S1], likely related to deferred tax asset realization as ACGL's US subsidiaries became more profitable at higher rates — this is a one-time item and inflates GAAP NI above operating run-rate for that year.

**Assessment:** Operating income ($3.7B) is the more meaningful recurring earnings metric for ACGL. GAAP NI includes mark-to-market volatility on the $65B+ investment portfolio that creates noise. The divergence is transparent, well-disclosed, and consistent with insurance industry convention.

---

#### 2. Key Accounting Adjustments

Management's non-GAAP operating income excludes:

1. **Realized investment gains/losses** — portfolio dispositions that are partially discretionary
2. **Fair value changes on investment securities** — unrealized mark-to-market movements; most significant swing factor
3. **Intangible amortization** — primarily from acquisition goodwill ($1.22B at YE2025 [S2])
4. **Transaction costs / non-recurring items** — bolt-on acquisition expenses when incurred

**FY2025 GAAP vs. Operating Bridge:**
- GAAP NI: $4.40B [S1]
- Operating NI: $3.70B [S2]
- Difference: +$0.70B — net of after-tax unrealized/realized gains (investment portfolio benefited from tightening spreads and equity markets in H2 2025)

Note that in FY2022, the reverse occurred: GAAP NI was $1.48B [S1] vs. an estimated operating NI likely above $2B, as rising rates caused significant unrealized losses on the fixed income portfolio (AOCI fell to −$1.65B by YE2022 [S1]). This pattern demonstrates that GAAP NI is volatile; operating NI is more signal.

---

#### 3. Balance Sheet Quality

##### 3a. Investment Portfolio

Total assets of $79.24B at YE2025 [S1] are dominated by the investment portfolio (estimated ~$65B+ in invested assets, roughly $79.24B total assets minus ~$10.1B unearned premiums funding and ~$4–5B in other non-investment assets). The investment portfolio serves as:
- **Float deployment**: ACGL holds approximately $43.65B in float (loss reserves $33.55B + unearned premiums $10.10B [S1]) that is invested at the company's discretion — the fundamental economic advantage of the insurance business model
- Net investment income grew from $389M (2021) to $1.62B (FY2025) [S1], driven by the 2022–2024 rate hike cycle allowing reinvestment at significantly higher yields. The Q1 2026 run-rate of $408M/quarter [S1] suggests the portfolio is now fully repriced at a ~4–5% yield

The investment portfolio is stated to be predominantly investment-grade fixed income. Duration is matched to liability duration — a conservative, standard practice. AOCI at YE2025 was essentially flat (+$5M [S1]) after recovering from the −$1.65B trough in 2022, indicating the fixed income portfolio is roughly marked to par.

##### 3b. Goodwill and Intangibles

Goodwill of $1.22B at YE2025 [S2] (down from $1.35B at YE2024, likely amortization of identified intangibles from the Watford Holdings acquisition). At 5.0% of total equity ($24.21B), goodwill is not material enough to represent a balance sheet quality concern.

##### 3c. Debt Structure

Total debt has been remarkably stable at ~$2.73B for five consecutive years (2021–2025) [S2]. At 11.3% of equity and 3.4% of total assets, leverage is very modest by insurance industry standards. ACGL relies on **economic leverage through float**, not financial leverage through debt — a high-quality, sustainable model.

##### 3d. Reserve Adequacy Indicators

The consistent growth in loss reserves reflects premium growth rather than adverse development (reserves $17.76B in 2021 → $33.55B in 2025 [S1], roughly 3.3× the 2021 NPE). The reserve-to-NPE ratio has been stable at ~1.9–2.0×, within normal bounds for a mixed short/long-tail book. Favorable PPD history supports adequacy, though long-tail casualty uncertainty remains.

---

#### 4. Cash Flow Quality

| Year | Operating CF | CapEx | Free CF | GAAP Net Income |
|------|-------------|-------|---------|-----------------|
| FY2025 | $6.17B | ($44M) | $6.13B | $4.40B |
| FY2024 | $6.67B | ($51M) | $6.62B | $4.31B |
| FY2023 | $5.75B | ($52M) | $5.70B | $4.44B |
| FY2022 | $3.82B | ($50M) | $3.77B | $1.48B |
| FY2021 | $3.42B | ($41M) | $3.38B | $2.16B |

*Sources: [S1] for GAAP NI; [S2] for CF statement*

**Structural note:** For insurance companies, operating cash flow (OCF) consistently exceeds GAAP net income because:
1. Loss reserves are a non-cash accrual added to claims expense but not immediately paid
2. Unearned premium growth represents cash received upfront before it flows through the P&L
3. This is economically meaningful — it represents growing float invested at positive yields

FY2025 OCF of $6.17B [S2] vs. GAAP NI of $4.40B = a 1.4× "cash conversion" ratio. This is *expected and normal* for a growing insurance group — not a red flag. CapEx is negligible ($44M [S2]) for this asset-light model.

---

#### 5. MANDATORY Adversarial Research Sweep

> **Transcript analysis not performed (coverage-next-full path). Adversarial findings based on publicly available data in source files and structural/fundamental analysis.**

##### 5a. Short Seller Thesis (Public Record)

No significant dedicated short-seller report targeting ACGL has been identified in the available data. ACGL is not a typical short-seller target — it has a clean 25-year operating history, no allegations of financial fraud, and a transparent Bermuda holding company structure that is standard in the specialty insurance industry. However, structural bear arguments exist:

##### 5b. Reserve Adequacy — Primary Bear Risk

The single most credible bear thesis is **casualty reserve deficiency in long-tail lines**. Bears point to:
- Rapid premium growth in Insurance segment (casualty/liability/professional lines) from 2020–2024: gross premiums written doubled from $10.1B (2020) to $22.9B (2025) [S1]. Casualty reserving for these accident years will not be fully developed until 2027–2032
- Industry-wide reserve deficiencies at peers (Travelers, Markel, others) for 2019–2022 accident years driven by social inflation, nuclear verdicts, and economic inflation in medical/legal costs
- ACGL's Insurance segment combined ratio of ~91% (FY2025) implies a loss ratio in the mid-to-high 70s — thin margin for error if development is adverse
- Management publishes ultimate loss estimates annually but actuarial uncertainty bands are wide for long-tail lines

**Assessment:** This is a legitimate risk. ACGL's favorable PPD track record is a mitigant, but the scale of recent growth and the industry social inflation environment are genuine concerns. No evidence of actual adverse development in the data reviewed.

##### 5c. Mortgage Segment — Recession/Housing Risk

The Mortgage segment operates as a private mortgage insurer (PMI), covering lenders against borrower default on high-LTV mortgages. This business is **explicitly pro-cyclical**: if unemployment rises sharply or housing prices decline materially, claim frequencies in the insured mortgage pool surge.

- Current mortgage combined ratio of 13–35% [S2] reflects an extremely benign credit environment (low unemployment, stable home prices)
- The mortgage segment is a significant profit contributor at current conditions
- In a housing downturn scenario comparable to 2008–2012, the segment could swing from major profit contributor to meaningful loss absorber
- PMIERS (Private Mortgage Insurer Eligibility Requirements) require capital buffer; Arch is compliant

**Assessment:** Real tail risk in a recession scenario, but currently generating exceptional returns. Arch actively manages this via PMIERS compliance and diversification.

##### 5d. P&C Rate Softening and Premium Growth Deceleration

NPW growth has decelerated sharply: +21% (2021) → +23% (2022) → +22% (2023) → +17% (2024) → +5% (2025) [computed from S1]. This deceleration reflects:
- Insurance P&C market pricing beginning to soften after the 2020–2024 hard market cycle
- ACGL exercising discipline by choosing not to write at margins below hurdle rates (a positive sign, but reduces growth)
- Reinsurance market remains firmer than primary insurance market

Bears argue the golden era of underwriting (2020–2024 hard market, combined ratios in the low-80s) is ending, and 2026–2028 could see margin compression as capacity flows back into the market.

##### 5e. Bermuda Pillar Two Tax Drag

Effective January 1, 2025, Bermuda implemented the OECD Pillar Two 15% global minimum corporate income tax. ACGL's effective tax rate was effectively 0–5% for most of its history (Bermuda domicile, with U.S. subsidiary taxes offsetting). The 2025 income tax expense of $760M [S1] on $5.16B pretax income = 14.7% effective rate — already reflected in FY2025 results.

Bears note:
- This is a structural, permanent increase in ACGL's tax burden vs. history
- ROE will be modestly lower than the pre-Pillar Two regime suggests
- Management has acknowledged this; guidance incorporates the higher rate

**Assessment:** Already priced into 2025 results. Not a hidden risk — but does compress after-tax economics vs. pre-2025 comparisons.

##### 5f. Regulatory Actions

No current material regulatory actions, SEC enforcement proceedings, or state Department of Insurance (DOI) adverse actions have been identified in the available source data. ACGL is regulated by the Bermuda Monetary Authority (BMA) as a Class 4/E insurer and its U.S. subsidiaries are regulated by the relevant state DOIs.

##### 5g. CEO Compensation Concern

The 347% increase in CEO Nicolas Papadopoulo's compensation to $31.7M (FY2024) — driven by a $23M special outperformance equity award at appointment [S3] — is high relative to peers and could represent an incremental governance concern. The Say-on-Pay vote received strong approval (280M shares in favor [S3]), suggesting shareholders are not alarmed, but the magnitude is notable.

---

#### Summary Financial Quality Assessment

| Dimension | Assessment | Notes |
|-----------|-----------|-------|
| Revenue recognition | High quality | Premiums earned ratably; no manipulation risk |
| Loss reserve adequacy | Moderate risk | Conservative history, but long-tail casualty is inherently uncertain |
| Investment portfolio | High quality | Investment-grade fixed income; duration matched |
| GAAP vs. operating | Transparent | Primary swing = unrealized gains; well-disclosed |
| Cash flow quality | High quality | OCF > NI is expected for growing insurer; not a red flag |
| Debt / leverage | Low risk | $2.73B debt, stable 5 years; economic leverage via float |
| Goodwill | Low risk | $1.22B, 5% of equity |
| Tax structure | Notable | Pillar Two 15% now baked in; permanent change from pre-2025 regime |

**Overall: High quality financials with the primary risk being long-tail casualty reserve adequacy — a known, structural risk for specialty insurers that cannot be assessed without actuarial data.**

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/ACGLN/fundamental

## Navigation

- Overview: /stocks/ACGLN
- Financials (this page): /stocks/ACGLN/financials
- Thesis: /stocks/ACGLN/thesis
- Investment Memo: /stocks/ACGLN/memo
- Coverage universe: /stocks